Scholarly Index
Hubert Schrezenmeier
German Red Cross; 24,893 total citations; 575 total publications; best world rank #14
German Red Cross
24,893Total citations
575Total publications
84H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Complement system in diseases | Lifetime | 53 | DE 3 | 99.05 |
| Mesenchymal stem cell research | Lifetime | 185 | DE 7 | 98.89 |
| Blood groups and transfusion | Lifetime | 151 | DE 10 | 98.58 |
| Renal Diseases and Glomerulopathies | Lifetime | 176 | DE 13 | 98.90 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 214 | DE 20 | 99.04 |
| COVID-19 Clinical Research Studies | Lifetime | 713 | DE 27 | 97.47 |
| Blood disorders and treatments | Lifetime | 314 | DE 25 | 96.36 |
| Platelet Disorders and Treatments | Lifetime | 886 | DE 58 | 96.02 |
| Polyomavirus and related diseases | Lifetime | 682 | DE 61 | 95.08 |
| Blood donation and transfusion practices | Lifetime | 832 | DE 45 | 85.93 |
| Complement system in diseases | 2021-2025 | 14 | DE 1 | 98.61 |
| COVID-19 Clinical Research Studies | 2021-2025 | 522 | DE 22 | 97.65 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 143 | DE 12 | 96.93 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 922 | DE 37 | 96.58 |
| Blood groups and transfusion | 2021-2025 | 205 | DE 10 | 91.22 |
| Platelet Disorders and Treatments | 2021-2025 | 564 | DE 49 | 85.73 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 436 | DE 70 | 83.87 |